Anthem Biosciences Limited (ANTHEM) — Financial Results
Anthem Biosciences Limited announced that its designated insiders are barred from trading company shares from July 1, 2026 until 48 hours after the board meeting approving the June 30, 2026 quarter results, as required under SEBI insider trading regulations.
About Anthem Biosciences Limited (ANTHEM)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
📡 Get AI alerts when ANTHEM files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track ANTHEM — Free💡 Ask AI about this filing
📊 More ANTHEM filings
- 🔴 Financial Results — 21 July 2026 Anthem Biosciences reported consolidated revenue of ₹4,182 Mn for Q1FY27, down 22.6% YoY, with EBITD...
- 🔴 Financial Results — 21 July 2026 Anthem Biosciences reported consolidated revenue of ₹4,182 crores for Q1FY27, down 22.6% YoY, with E...
- 🔴 Financial Results — 21 July 2026 Anthem Biosciences reported Q1FY27 consolidated revenue of ₹4,182 Mn, down 22.6% YoY, with EBITDA at...
- 🟡 Board Meeting — 21 July 2026 Anthem Biosciences announced the outcome of its board meeting held on July 21, 2026, where it approv...
- Financial Results — 2 July 2026 Anthem Biosciences clarified that its FY2026 PAT of ₹5,917.92 million matches the XBRL filing, corre...
🔥 Also filed on 26 June 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
📡 Get AI alerts when ANTHEM files new disclosures
Track ANTHEM filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track ANTHEM — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research